RELYLO Trademark

Trademark Overview


On Thursday, March 29, 2012, a trademark application was filed for RELYLO with the United States Patent and Trademark Office. The USPTO has given the RELYLO trademark a serial number of 85583753. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2015. This trademark is owned by Glaxo Group Limited. The RELYLO trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, meta...
relylo

General Information


Serial Number85583753
Word MarkRELYLO
Filing DateThursday, March 29, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "RELYLO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 5, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Monday, November 16, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 16, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2015EXTENSION 5 GRANTED
Thursday, March 26, 2015EXTENSION 5 FILED
Thursday, March 26, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 4 GRANTED
Tuesday, September 30, 2014EXTENSION 4 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2014EXTENSION 3 GRANTED
Tuesday, April 1, 2014EXTENSION 3 FILED
Tuesday, April 1, 2014TEAS EXTENSION RECEIVED
Friday, November 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2013EXTENSION 2 GRANTED
Wednesday, October 2, 2013EXTENSION 2 FILED
Wednesday, November 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Friday, April 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2013EXTENSION 1 GRANTED
Wednesday, April 3, 2013EXTENSION 1 FILED
Wednesday, April 3, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 16, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 23, 2012ASSIGNED TO EXAMINER
Thursday, April 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 2, 2012NEW APPLICATION ENTERED IN TRAM